Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Biote Corp has a consensus price target of $8.65 based on the ratings of 7 analysts. The high is $11 issued by Cowen & Co. on June 24, 2022. The low is $6.55 issued by Jefferies on February 1, 2024. The 3 most-recent analyst ratings were released by Roth MKM, B. Riley Securities, and Jefferies on March 13, 2024, February 20, 2024, and February 1, 2024, respectively. With an average price target of $8.18 between Roth MKM, B. Riley Securities, and Jefferies, there's an implied 33.28% upside for Biote Corp from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Biote (NASDAQ:BTMD) was reported by Roth MKM on March 13, 2024. The analyst firm set a price target for $9.00 expecting BTMD to rise to within 12 months (a possible 46.58% upside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for Biote (NASDAQ:BTMD) was provided by Roth MKM, and Biote reiterated their buy rating.
There is no last upgrade for Biote
There is no last downgrade for Biote.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biote, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biote was filed on March 13, 2024 so you should expect the next rating to be made available sometime around March 13, 2025.
While ratings are subjective and will change, the latest Biote (BTMD) rating was a reiterated with a price target of $8.00 to $9.00. The current price Biote (BTMD) is trading at is $6.14, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.